Skip to content
Tenfell
Awarded contract
Published 20 Jan 2025

NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin

NHS England · London

Key facts

Awarded
19 Dec 2024
Contract starts
31 Mar 2025
Contract ends
31 Dec 2027
Procedure
Open procedure (above threshold)
Buyer type
Central government

Awarded to 6 suppliers

SupplierValue
Takeda UK Limited—
Octapharma Limited—
Grifols Uk Ltd—
Bio Products Laboratory—
CSL Behring UK Ltd—
LFB—

Description

NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin

Offer reference number: CM/PHS/23/5703

The period of the framework is 1 April 2025 to 31 December 2027 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 15 months. The total maximum framework agreement duration, including extension options, will be no more than 48 months.

Categories (CPV)

Similar open tenders

About NHS England

Their tenders, awards, contracts coming up for renewal, decision makers and committee papers.

View buyer profile

Their other open tenders

Published by the buyer on Contracts Finder (Open Government Licence v3.0). Always read the original notice before responding.